Home COVID-19 care surged as Japan s hospitals filled up, but treatment options were limited japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Heat sake like they do at a Japanese izakaya with this special at-home set japantoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantoday.com Daily Mail and Mail on Sunday newspapers.
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched the anticancer agent EZH2 inhibitor “Tazverik® Tablets 200 mg” (tazemetostat hydrobromide), in Japan with the indication of relapsed or refractory EZH2 gene mutation-positive follicular lymphoma (only when standard .
Although the government has taken some measures to support foreign nationals unable to return to their countries because of the pandemic, many were not eligible.